Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1166 ARTÍCULOS , VIENDO DEL 316 AL 330

The relationship between iron dyshomeostasis and amyloidogenesis in Alzheimer's disease: Two sides of the same coin

Peters DG, Connor JR, Meadowcroft MD.

Neurobiol Dis. 2015 Sep;81:49-65. doi: 10.1016/j.nbd.2015.08.007. Epub 2015 Aug 22.

Treated Behavioral Symptoms and Mortality in Medicare Beneficiaries in Nursing Homes with Alzheimer's Disease and Related Dementias

Huang TY, Wei YJ, Moyo P, Harris I, Lucas JA, Simoni-Wastila L.

J Am Geriatr Soc. 2015 Sep;63(9):1757-65. doi: 10.1111/jgs.13606. Epub 2015 Aug 27.

Alzheimer's disease: rare variants with large effect sizes

Del-Aguila JL, Koboldt DC, Black K, Chasse R, Norton J, Wilson RK, Cruchaga C.

Curr Opin Genet Dev. 2015 Aug;33:49-55. doi: 10.1016/j.gde.2015.07.008. Epub 2015 Aug 22.

Vascular dysfunction in the pathogenesis of Alzheimer's disease--A review of endothelium-mediated mechanisms and ensuing vicious circles

Di Marco LY, Venneri A, Farkas E, Evans PC, Marzo A, Frangi AF.

Neurobiol Dis. 2015 Oct;82:593-606. doi: 10.1016/j.nbd.2015.08.014. Epub 2015 Aug 23.

Derouesné C.

Geriatr Psychol Neuropsychiatr Vieil. 2015 Jun;13(2):177-8.

The keystone of Alzheimer pathogenesis might be sought in Aβ physiology

Puzzo D, Gulisano W, Arancio O, Palmeri A.

Neuroscience. 2015 Oct 29;307:26-36. doi: 10.1016/j.neuroscience.2015.08.039. Epub 2015 Aug 24.

Alzheimer's Disease: Genomics and Beyond

Song F, Han G, Bai Z, Peng X, Wang J, Lei H.

Int Rev Neurobiol. 2015;121:1-24. doi: 10.1016/bs.irn.2015.05.001. Epub 2015 Jun 19.

Genetic Analysis of Association Between Calcium Signaling and Hippocampal Activation, Memory Performance in the Young and Old, and Risk for Sporadic Alzheimer Disease

Heck A, Fastenrath M, Coynel D, Auschra B, Bickel H, Freytag V, Gschwind L, Hartmann F, Jessen F, Kaduszkiewicz H, Maier W, Milnik A, Pentzek M, Riedel-Heller SG, Spalek K, Vogler C, Wagner M, Weyerer S, Wolfsgruber S, de Quervain DJ, Papassotiropoulos A.

JAMA Psychiatry. 2015 Oct;72(10):1029-36. doi: 10.1001/jamapsychiatry.2015.1309.

LIFTING THE CURSE OF ALZHEIMER'S

Stix G.

Sci Am. 2015 May;312(5):50-7. doi: 10.1038/scientificamerican0515-50.

The Impact of Docosahexaenoic Acid on Alzheimer's Disease: Is There a Role of the Blood-Brain Barrier?

Pan Y, Khalil H, Nicolazzo JA.

Curr Clin Pharmacol. 2015;10(3):222-41. doi: 10.2174/157488471003150820151532.

Do statins prevent Alzheimer's disease? A narrative review

Daneschvar HL, Aronson MD, Smetana GW.

Eur J Intern Med. 2015 Nov;26(9):666-9. doi: 10.1016/j.ejim.2015.08.012. Epub 2015 Sep 2.

Metabolic profiling distinguishes three subtypes of Alzheimer's disease

Bredesen DE.

Aging (Albany NY). 2015 Aug;7(8):595-600. doi: 10.18632/aging.100801.

Nanotechnology-based drug delivery systems for the treatment of Alzheimer's disease

Fonseca-Santos B, Gremião MP, Chorilli M.

Int J Nanomedicine. 2015 Aug 4;10:4981-5003. doi: 10.2147/IJN.S87148. eCollection 2015.

Estrogen receptor 1 PvuII and XbaI polymorphisms and susceptibility to Alzheimer's disease: a meta-analysis

Lee YH, Song GG.

Genet Mol Res. 2015 Aug 10;14(3):9361-9. doi: 10.4238/2015.August.10.17.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias